Next Article in Journal
Bright Light Therapy for Major Depressive Disorder in Adolescent Outpatients: A Preliminary Study
Previous Article in Journal
Match and Mismatch between Lived Experiences of Daytime Sleepiness and Diagnostic Instruments: A Qualitative Study amongst Patients with Sleep Disorders
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Sleep Efficiency and Sleep Onset Latency in One Saskatchewan First Nation

1
Canadian Centre for Rural and Agricultural Health, University of Saskatchewan, 104 Clinic Place, Saskatoon, SK S7N 2Z4, Canada
2
Department of Community Health & Epidemiology, College of Medicine, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada
3
Department of Medicine, University of Saskatchewan, Royal University Hospital, 103 Hospital Drive, Saskatoon, SK S7N 0W8, Canada
4
Department of Academic Family Medicine, University of Saskatchewan, West Winds Primary Health Centre, 3311 Fairlight Drive, Saskatoon, SK S7M 3Y5, Canada
5
Community A, P.O. Box 96, Duck Lake, SK S0K 1J0, Canada
6
College of Nursing, University of Saskatchewan, 104 Clinic Place, Saskatoon, SK S7N 2Z4, Canada
*
Author to whom correspondence should be addressed.
Clocks & Sleep 2024, 6(1), 40-55; https://doi.org/10.3390/clockssleep6010004
Submission received: 27 November 2023 / Revised: 3 January 2024 / Accepted: 5 January 2024 / Published: 10 January 2024
(This article belongs to the Section Human Basic Research & Neuroimaging)

Abstract

:
Background: Sleep efficiency and sleep onset latency are two measures that can be used to assess sleep quality. Factors that are related to sleep quality include age, sex, sociodemographic factors, and physical and mental health status. This study examines factors related to sleep efficiency and sleep onset latency in one First Nation in Saskatchewan, Canada. Methods: A baseline survey of the First Nations Sleep Health project was completed between 2018 and 2019 in collaboration with two Cree First Nations. One-night actigraphy evaluations were completed within one of the two First Nations. Objective actigraphy evaluations included sleep efficiency and sleep onset latency. A total of 167 individuals participated, and of these, 156 observations were available for analysis. Statistical analysis was conducted using logistic and linear regression models. Results: More females (61%) than males participated in the actigraphy study, with the mean age being higher for females (39.6 years) than males (35.0 years). The mean sleep efficiency was 83.38%, and the mean sleep onset latency was 20.74 (SD = 27.25) minutes. Age, chronic pain, ever having high blood pressure, and smoking inside the house were associated with an increased risk of poor sleep efficiency in the multiple logistic regression model. Age, chronic pain, ever having anxiety, heart-related illness, and smoking inside the house were associated with longer sleep onset latency in the multiple linear regression model. Conclusions: Sleep efficiency and sleep onset latency were associated with physical and environmental factors in this First Nation.

1. Introduction

Sleep efficiency, the amount of time actually spent sleeping while in bed as a percentage, and sleep onset latency, the length of time it takes to fall asleep, are two measures that can be used to assess sleep quality [1]. Other measures are sleep waking (how many times the person wakes during the night) and wakefulness (how many minutes are spent awake during the night after sleep onset) [1]. Many studies have shown that factors related to sleep quality include age [2,3], sex [2,4], sociodemographic factors [5,6,7,8,9], smoking [10,11], health conditions including hypertension [3,4,12,13,14,15,16,17,18,19,20,21], cardiovascular disease [4,22,23,24,25,26], diabetes [27], heart failure [28], mental health issues including cognitive impairment and Alzheimer’s disease [29], anxiety [30,31,32,33,34], and depression [3]. Other sleep-related variables such as pain [35,36,37,38,39], bad dreams [2,40], nocturia [2], environmental noise [41], and secondhand smoke [42,43,44,45] were also related to sleep quality. Sleep medications significantly increase total sleep time and sleep efficiency and decrease sleep onset latency [46]. In addition, physical activity [47] and energy expenditure [48] are also associated with sleep efficiency. It is also known that psychological disorders [49,50], cardiovascular disease [51,52], and metabolic effects [53,54] are associated with shorter sleep duration.
Recent findings from the 2022 Canadian Community Health Survey reported that among adults aged 18 to 64, 61% reported high sleep quality, compared with 71% among adults aged 65 and older [55]. However, this survey excluded people living on First Nations reserves and other Indigenous settlements. Therefore, little is known about sleep quality, including sleep efficiency and sleep onset latency, among First Nations peoples in Canada. Also, there are no studies reported in the literature about risk factors and their possible associations with sleep efficiency and sleep onset latency in First Nations peoples. To bridge the gap in this current research, the objective of this study was to examine the factors related to sleep efficiency and sleep onset latency in one First Nation in Saskatchewan, Canada.

2. Results

In this one-night actigraphy study, more females (61%) participated than males. The mean age is higher for females than the males who participated (Table 1). The total sleep time was low (<6 h) during this one-night study. The mean sleep efficiency was 83.38%, and the mean sleep onset latency was 20.74 (SD = 27.25) minutes (Table 2) from the one-night actigraphy data. Sleep efficiency (%) data were normally distributed (the Kolmogorov–Smirnov test was used to test for normality with the resulting statistics = 0.063; df = 156; p = 0.200). The median of one-night actigraphy measured sleep efficiency was 83.92%. According to the definition, 55.1% (86/156) had poor sleep efficiency, and 44.9% (70/156) had good sleep efficiency. With the same cutoffs for self-reported sleep efficiency, 7.8% (12/153) had poor sleep efficiency. Sleep efficiency by objective (actigraphy) measurement and the self-reported subjective (using PSQI) measurement of sleep efficiency were both available for 153 participants. Sleep efficiency objective (actigraphy) measurements (83.33%; SD = 7.91%) were significantly different from self-reported subjective (using PSQI) measurements (94.19%; SD = 6.13%) of sleep efficiency (Table 2). The p-value was <0.0001. A paired-t test analysis revealed that log-transformed 126 sleep onset latency self-reported measurements (1.27; SD = 0.43) were not significantly different from sleep onset latency objective measurements (1.21; SD = 0.43) by actigraphy (p-value was 0.245).
Univariable analysis showed that ever high blood pressure and smoking inside the home were significantly associated (p < 0.05) with an increased risk of poor sleep efficiency (Table 3). In addition, education, smoking status, chronic pain, having ever had a respiratory illness, a moldy or musty smell, and signs of mold in any living area served as candidate variables (p < 0.25) for multivariable analysis. Age, sex, taking prescription medication on a regular basis, and drinking caffeinated beverages within two hours of going to bed were candidate variables for the multivariable regression model because of their clinical importance. The multivariable logistic regression model showed that age, chronic pain, ever having high blood pressure, and smoking inside the home were associated with an increased risk of poor sleep efficiency (Table 4).
Table 5 shows the results of univariable and multivariable linear regression analyses of log-transformed sleep onset latency (N = 126). Regression coefficients transformed to the original scale are shown in Table 5 within brackets. The coefficient of determination (R2) of the multivariable regression model is 0.206. Longer sleep onset latency was associated with the participant’s age, exposure to smoke inside the home, chronic pain, and those who have been diagnosed with anxiety or a heart-related illness.

3. Discussion

In the current study, we explored the prevalence of sleep efficiency, sleep onset latency, and associated risk factors in one First Nation. The main observations were that the mean sleep efficiency was somewhat lower than the reference range (85.0%) [56], and the mean sleep onset latency was somewhat greater than the reference range (10–20 min) [57]. The prevalence of sleep efficiency of ≤85% was 55.1%. The prevalence of sleep onset latency >20 min was 34.0%. Among Canadian adults aged 18 years and older, the mean sleep duration was 8.0 h per night, with 72.7% meeting sleep duration recommendations [49]. In the current study, sleep duration was lower (5.8 h) than Canadian norms. Shorter sleep duration could lead to many health problems, such as psychological and mental disorders [49,50], cardiovascular diseases [51,52], and issues with metabolic systems [53,54]. Therefore, adequate sleep duration may be important for preventing these health problems. Factors associated with poor sleep efficiency were age, chronic pain, high blood pressure, and exposure to smoke inside the home. Factors associated with longer sleep onset latency were age, exposure to smoke inside the home, chronic pain, and being diagnosed with anxiety and heart-related illnesses.
One of the factors associated with sleep efficiency and sleep onset latency is age. Studies have shown that sleep quality changes with age [2,3]. Desjardins et al. [2] reported that poor sleep efficiency was prevalent among older people. Another cross-sectional study by Didikoalu et al. [3] reported that with the increase in age, there was a decrease in sleep efficiency. In adults, sleep onset latency increases gradually with age [58]. In contrast to these studies, the current study found a higher risk of poor sleep efficiency among the 18- to 54-year-old age group compared to the 55-year-old and older age groups. Similar to poor sleep efficiency, a higher risk of longer sleep onset latency was associated with the 18- to 54-year-old age group.
Studies have shown a relationship between sleep quality and chronic pain [35,36,37,38,39]. The results from a cross-sectional study showed a positive direct effect of chronic pain on poor sleep quality and poor sleep efficiency [35]. Abeler et al. [36] reported that participants with chronic musculoskeletal pain exhibited more subjective sleep disturbance and moderately worse sleep efficiency compared to pain-free controls. There was a close interaction between central sensitization and sleep disturbances in people with chronic pain [38]. These researchers have also shown that this interaction was bidirectional. Smith et al. [59] reported that sleep quality and pain intensity were related, and sleep quality was related to the patient’s mood and physical function factors [39]. Similar to sleep efficiency, there was a link between sleep onset latency and the intensity of chronic pain [37]. This study reported a 3.5-fold higher risk of poor sleep efficiency in people with chronic pain. Further, people with chronic pain have longer sleep onset latency.
Canadian First Nation peoples living on-reserve have higher rates of non-traditional use of tobacco than those living off-reserve [60,61]. Aboriginal peoples were also twice as likely to be exposed to second-hand smoke in the home [62]. Studies have shown that smoke exposure is related to sleep quality [42,43,44,45]. A study of never-smokers revealed that exposure to secondhand smoke, frequency, and duration of exposure were associated with poor sleep quality and sleep onset latency in never-smoking adults overall [43]. The authors also reported a dose-response (frequency and duration of exposure) relationship between secondhand smoke exposure and poor sleep quality and sleep onset latency among women but not in men [43]. Zandy et al. [42] reported that secondhand smoke exposure is associated with sleep duration, trouble falling and staying asleep, and sleep dissatisfaction. Another study by Valentino et al. [44] reported that young adults who self-reported higher levels of secondhand smoke exposure were also more likely to report sleep disturbances and lower sleep quality. Toyama et al. [45] reported that associations were found between secondhand smoke exposure and both poor sleep quality and sleep bruxism. This study further confirmed the available evidence. There was a 2.9-fold higher risk of poor sleep efficiency in people exposed to secondhand smoke. Further, people exposed to secondhand smoke have longer sleep onset latency.
Studies have shown an association between hypertension and sleep efficiency [3,4,12,13,15,17,18]. Yuan and others [12] reported that in a population of young and middle-aged populations, habitual sleep efficiency in the <65–75% group had an increased risk of developing hypertension compared to their counterparts. Another study reported that increased sleep efficiency was independently associated with lower systolic blood pressure [13]. A cross-sectional study of Japanese adults showed that reduced sleep efficiency was significantly associated with an increased prevalence of hypertension [15]. A study of young adolescents reported that higher sleep efficiency was associated with lower metabolic risk scores [17]. Another study of a healthy old age cohort revealed that sleep efficiency decreased with increasing age. Also, compared with low sleep efficiency, belonging to a high sleep efficiency group was associated with having a lower prevalence of hypertension and circulatory problems [3]. In another study, sleep efficiency was associated with higher systolic blood pressure [18]. This current study supports the evidence and reports that poor sleep efficiency is associated with high blood pressure.
This study reported that having a heart problem or atrial fibrillation was associated with sleep onset latency. Not many studies support this observation. One study of rural older adults in China revealed that poor sleep quality, including prolonged sleep onset latency and reduced sleep efficiency, was significantly associated with female sex and clinical co-morbidities such as hypertension, coronary heart disease, and chronic obstructive pulmonary disease [4]. In another study, clinical heart failure predicted a reduction in sleep quality, as indicated by sleep onset latency and sleep quality components of the Pittsburgh Sleep Quality Index [28].
Studies have shown an association between anxiety disorders and sleep disturbances. Patients with panic disorder reported longer sleep onset latency, increased time awake, and reduced sleep efficiency [31,33,34]. Sleep onset latency changes were associated with anxiety [30]. A study by Farris and others [32] indicated that anxiety sensitivity was significantly correlated with disturbances in sleep duration, subjective sleep quality, and sleep onset latency. This study also showed a positive correlation between longer sleep onset latency and whether the individual was ever diagnosed with anxiety.

Strengths and Limitations

The strengths of this study included the fairly large number of participants and the inclusion of a number of potential factors, including lifestyle, sociodemographic, and sleep characteristics. This study is the first to our knowledge to examine sleep efficiency and sleep onset latency in adults living in a rural Cree First Nation in Saskatchewan, Canada, using actigraphy. However, one of the limitations is that the actigraphy was limited to one night. It has been recommended that at least five nights be spent assessing a reliable measure of sleep efficiency [63]. There were a few other concerns, such as not wearing the equipment during the entire night and the need to repeat the test if the information was not recorded. The average number of awakes was higher in this population compared to the general population, which needs further investigation.
The questionnaire survey data were self-reported, with possible recall bias. The willingness to participate in an actigraphy test was 40% (167/418) of those who completed the survey questionnaire. However, the participants in this sample volunteered for follow-up. Therefore, this is not a random sample of the population. An additional consideration in this study was that the population was young [mean age 35 years (SD = ±14.6 years) for males and 39.6 years (SD = ±14.9 years) for females]. Although associations of several factors were observed with sleep efficiency and sleep onset latency, causal relations could not be assessed due to the cross-sectional nature of the data.

4. Materials and Methods

4.1. Study Sample

The baseline survey of the First Nations Sleep Health Project (FNSHP) was completed between 2018 and 2019 in collaboration with the two Cree First Nations (Community A and Community B) in Saskatchewan, Canada. The methods were published elsewhere [64,65,66] and are only briefly described here. The overall goal of the FNSHP was to study the relationships between sleep disorders, risk factors, and co-morbidities and to evaluate local diagnosis and treatment. A Certificate of Approval was obtained from the University of Saskatchewan’s Biomedical Research Ethics Board (Certificate No. Bio #18-110). In addition, adherence to Chapter 9 (Research Involving the First Nations, Inuit, and Metis Peoples of Canada) in the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans was undertaken [67]. Participants provided written consent prior to engaging in this research project.

4.2. Data Collection

Research assistants were hired from the communities and trained to conduct the baseline surveys in their respective communities. Data were collected via interviewer-administered questionnaires (in Community A and B) and clinical assessments (only conducted in Community A). The survey collected information on demographic variables and individual and contextual determinants of sleep health. Objective clinical measurements included a Level 3 home overnight sleep test and actigraphy. This manuscript is based on data from the questionnaires and one-night home actigraphy collected in Community A.

4.2.1. Clinical Measurements

Anthropometric measurements (abdominal girth, neck circumference, hip circumference, height, and weight) were obtained. Height was measured against a wall using a fixed tape measure, with participants standing in socks on a hard floor. Weight was measured using a calibrated spring scale with participants in socks and dressed in indoor clothing. Using clinical measures of weight and height, body mass index (BMI) was calculated based on the equation BMI = weight (in kilograms)/(height (in meters))2 [68].
Trained research assistants prepared the actigraphy device (Phillips Respironics Actiwatch (AW) Spectrum Plus wristband device: ©Philips Respironics, Bend, OR, USA) before positioning the device on the left or right wrist. Once the Actiwatch was returned after wearing it for at least one night, the research assistants downloaded the results and checked to see if the test had been properly recorded. If yes, the participant was given an honorarium for completing the survey questionnaire and a one-night home test. If not, the participant was invited to redo the test. They were given an honorarium regardless of the successful completion of a test.
Objective sleep measurements (actigraphy) provide the bedtime, get-up time, time in bed (hours), total sleep time (hours), sleep onset latency (minutes), sleep efficiency (%), wake time after sleep onset (WASO) (minutes), and number of awakenings. Self-reported sleep measurements and the Pittsburgh Sleep Quality Index (PSQI) [69] were used to measure seven individual components: subjective sleep quality, sleep efficiency, sleep onset latency, sleep duration, sleep disturbances, use of sleep medication, and daytime dysfunction over the last month. This paper only considered two components: sleep efficiency and sleep onset latency.
Of the 233 persons who participated in a one-night sleep study, 168 participants completed one night of sleep actigraphy during July–December 2018 and May–August 2019. Examining the readings from the actigraphy, 12 minimal sleep periods of less than 180 min (3 h) were excluded from the analysis [70]. One hundred and fifty-six observations were available for analysis. Of those, self-reported sleep quality was available for 153 participants. For both log-transformed sleep onset latency and self-reported sleep onset latency, 126 observations were available for the analysis.

4.2.2. Definitions

Sleep efficiency from the Pittsburgh Sleep Quality Index (PSQI) and actigraphy was defined as sleep efficiency = (total # hours asleep)/(total # of hours in bed) × 100. For logistic regression modeling, cutoffs of >85% as good sleep efficiency and ≤85% as poor sleep efficiency were used [69]. Sleep onset latency, was defined as the time it takes a person to fall asleep after turning off the lights [1].

4.2.3. Statistical Analysis

Statistical analyses were conducted using SPSS version 28 [IBM Corp. Released 2022. IBM SPSS Statistics for Windows, Version 28.0. Armonk, NY, USA: IBM Corp.]. Descriptive statistics, mean, median, and standard deviation (SD) were reported for continuous variables, and the p-value of the paired t-test was reported when comparing the means of paired samples. For categorical variables, frequency and percentages (%) were reported.
We used data obtained from actigraphy rather than self-reported data to determine the association between outcomes of sleep efficiency and sleep onset latency with independent variables of interest. Chi-squared tests were used to determine the univariable association of sleep efficiency prevalence with independent variables of interest. Multivariable logistic regression models were used to predict the relationship between a binary outcome of sleep efficiency (good or poor) and a set of explanatory variables. A series of logistic regression models were fitted to determine whether potential risk factors, confounders, and interactive effects contributed significantly to the prediction of sleep efficiency.
Sleep onset latency was transformed by a common log transformation to normalize sleep onset latency data. Test of normality: the Kolmogorov–Smirnov statistic is 0.068 (df = 126) with a p-value of 0.200. Log-transformed sleep onset latency (>0 values) was used in the statistical analyses, and 27 observations with zero were not included in the analysis. A series of univariable linear regression models were run to identify the candidate variables for the multivariable linear regression model. Multivariable linear regression was used to analyze the relationship between the dependent variable of log-transformed sleep onset latency and the independent variables of interest. Based on the univariable analysis, variables with p < 0.20 and less than 25% missing information were candidates for the multivariable linear regression model. All statistically significant variables (p < 0.05), as well as important clinical factors (age, sex, chronic pain, use of prescription medication), were retained in the final multivariable regression model. Interactions between potential effect modifiers were examined and were retained in the final model if the p-value was <0.05.

5. Conclusions

Sleep efficiency and sleep onset latency were associated with physical and environmental factors in one First Nation. In this population, sleep efficiency was lower than the reference range, and sleep onset latency was greater than the reference range. Many reasons could be attributed to poor sleep, including a sleep disorder, a poor sleep environment, or another health condition. This study could suggest areas for further research to understand the sleep patterns among First Nation peoples.

Author Contributions

Conceptualization, J.A.D., S.A., M.K., P.P., D.C.R., S.K., N.K., M.F. and R.S.; data curation, B.P.R. and K.M.; formal analysis, C.P.K.; funding acquisition, J.A.D., S.A., M.K. and P.P.; investigation, J.A.D., S.A., M.F., M.K. and P.P.; methodology, J.A.D., P.P., S.A., M.K., C.P.K. and M.F.; project administration, P.P.; resources, J.S., R.S. and M.F.; supervision, J.A.D. and P.P.; visualization, S.A., J.S., W.S. and V.R.R.; writing—original draft preparation, C.P.K., P.P. and J.A.D.; writing—review and editing, J.A.D., C.P.K., B.P.R., K.M., S.A., D.C.R., S.K., N.K., J.S., W.S., V.R.R., M.F., M.K. and P.P. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by a grant from the Canadian Institutes of Health Research, “Assess, Redress, Re-assess: Addressing Disparities in Sleep Health among First Nations People”, CIHR MOP-391913-IRH-CCAA-11829-FRN PJT-156149.

Institutional Review Board Statement

This study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Biomedical Research Ethics Board of the University of Saskatchewan (Bio #18-110, date of approval: 21 June 2018).

Informed Consent Statement

Written informed consent has been obtained from all participants involved in the study.

Data Availability Statement

The First Nations community owns and controls the data, and the data are released as per the research agreements with the communities and the OCAP principles (https://fnigc.ca/ocap-training/) (accessed on 10 November 2023). Requests for data access can be made to the Chief and Council of the community at [email protected].

Acknowledgments

The First Nations Sleep Health Project Team consists of: James A. Dosman (Designated Principal Investigator, University of Saskatchewan, Saskatoon, SK, Canada); Punam Pahwa (Co-Principal Investigator, University of Saskatchewan, Saskatoon, SK, Canada); Malcolm King (Co-Principal Investigator, University of Saskatchewan, Saskatoon, SK, Canada); and Sylvia Abonyi (Co-Principal Investigator, University of Saskatchewan, Saskatoon, SK, Canada); Co-Investigators: Mark Fenton, Chandima P. Karunanayake, Shelley Kirychuk, Niels Koehncke, Joshua Lawson, Robert Skomro, Donna Rennie, and Darryl Adamko, Collaborators: Roland Dyck, Thomas Smith-Windsor, Kathleen McMullin, Rachana Bodani, John Gjerve, Bonnie Janzen, Vivian R. Ramsden, Gregory Marchildon, and Kevin Colleaux; Project Manager: Brooke Russell, Community Partners: Jeremy Seeseequasis, Clifford Bird, Roy Petit, Edward Henderson, Raina Henderson, and Dinesh Khadka. We are grateful for the contributions from elders and community leaders who facilitated the engagement necessary for the study, research assistants who worked, and all participants who engaged in this study.

Conflicts of Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this study. The funders had no role in the design of the study, in the collection, analysis, or interpretation of data, in the writing of the manuscript, or in the decision to publish the results.

Abbreviations

FNSHPFirst Nations Sleep Health Project
BMIBody mass index
AWActiwatch
WASOWake time after sleep onset
PSQIPittsburgh Sleep Quality Index
SPSSStatistical Package for the Social Sciences
SDStandard Deviation
OROdds ratio
CIConfidence interval

References

  1. National Sleep Foundation. What is sleep quality? In Sleep and You Articles; National Sleep Foundation: Washington, DC, USA, 2020; Available online: https://www.thensf.org/what-is-sleep-quality/ (accessed on 15 November 2022).
  2. Desjardins, S.; Lapierre, S.; Hudon, C.; Desgagné, A. Factors involved in sleep efficiency: A population-based study of community-dwelling elderly persons. Sleep 2019, 42, zsz038. [Google Scholar] [CrossRef] [PubMed]
  3. Didikoglu, A.; Maharani, A.; Tampubolon, G.; Canal, M.M.; Payton, A.; Pendleton, N. Longitudinal sleep efficiency in the elderly and its association with health. J. Sleep Res. 2020, 29, e12898. [Google Scholar] [CrossRef]
  4. Wang, P.; Song, L.; Wang, K.; Han, X.; Cong, L.; Wang, Y.; Zhang, L.; Yan, Z.; Tang, S.; Du, Y. Prevalence and associated factors of poor sleep quality among Chinese older adults living in a rural area: A population-based study. Aging Clin. Exp. Res. 2020, 32, 125–131. [Google Scholar] [CrossRef] [PubMed]
  5. Etindele Sosso, F.A.; Holmes, S.D.; Weinstein, A.A. Influence of socioeconomic status on objective sleep measurement: A systematic review and meta-analysis of actigraphy studies. Sleep Health 2021, 7, 417–428. [Google Scholar] [CrossRef] [PubMed]
  6. Patel, N.P.; Grandner, M.A.; Xie, D.; Branas, C.C.; Gooneratne, N. “Sleep disparity” in the population: Poor sleep quality is strongly associated with poverty and ethnicity. BMC Public Health 2010, 10, 475. [Google Scholar] [CrossRef]
  7. Anders, M.P.; Breckenkamp, J.; Blettner, M.; Schlehofer, B.; Berg-Beckhoff, G. Association between socioeconomic factors and sleep quality in an urban population-based sample in Germany. Eur. J. Public Health 2014, 24, 968–973. [Google Scholar] [CrossRef]
  8. Wu, W.; Wang, W.; Dong, Z.; Xie, Y.; Gu, Y.; Zhang, Y.; Li, M.; Tan, X. Sleep Quality and Its Associated Factors among Low-Income Adults in a Rural Area of China: A Population-Based Study. Int. J. Environ. Res. Public Health 2018, 15, 2055. [Google Scholar] [CrossRef]
  9. Mezick, E.J.; Matthews, K.A.; Hall, M.; Strollo, P.J., Jr.; Buysse, D.J.; Kamarck, T.W.; Owens, J.F.; Reis, S.E. Influence of race and socioeconomic status on sleep: Pittsburgh Sleep SCORE project. Psychosom. Med. 2008, 70, 410–416. [Google Scholar] [CrossRef]
  10. Zhang, L.; Samet, J.; Caffo, B.; Punjabi, N.M. Cigarette smoking and nocturnal sleep architecture. Am. J. Epidemiol. 2006, 164, 529–537. [Google Scholar] [CrossRef]
  11. Riedel, B.W.; Durrence, H.H.; Lichstein, K.L.; Taylor, D.J.; Bush, A.J. The relation between smoking and sleep: The influence of smoking level, health, and psychological variables. Behav. Sleep Med. 2004, 2, 63–78. [Google Scholar] [CrossRef]
  12. Yuan, Y.; Heizhati, M.; Wang, L.; Li, M.; Lin, M.; Gan, L.; Cai, X.; Yang, W.; Yao, L.; Wang, Z.; et al. Poor sleep quality is associated with new-onset hypertension in a diverse young and middle-aged population. Sleep Med. 2021, 88, 189–196. [Google Scholar] [CrossRef]
  13. Yiallourou, S.R.; Carrington, M.J. Improved sleep efficiency is associated with reduced cardio-metabolic risk: Findings from the MODERN trial. J. Sleep Res. 2021, 30, e13389. [Google Scholar] [CrossRef] [PubMed]
  14. Ma, C.C.; Gu, J.K.; Bhandari, R.; Charles, L.E.; Violanti, J.M.; Fekedulegn, D.; Andrew, M.E. Associations of objectively measured sleep characteristics and incident hypertension among police officers: The role of obesity. J. Sleep Res. 2020, 29, e12988. [Google Scholar] [CrossRef]
  15. Hirata, T.; Nakamura, T.; Kogure, M.; Tsuchiya, N.; Narita, A.; Miyagawa, K.; Nochioka, K.; Uruno, A.; Obara, T.; Nakaya, N.; et al. Reduced sleep efficiency, measured using an objective device, was related to an increased prevalence of home hypertension in Japanese adults. Hypertens. Res. 2020, 43, 23–29. [Google Scholar] [CrossRef] [PubMed]
  16. McMahon, D.M.; Burch, J.B.; Youngstedt, S.D.; Wirth, M.D.; Hardin, J.W.; Hurley, T.G.; Blair, S.N.; Hand, G.A.; Shook, R.P.; Drenowatz, C.; et al. Relationships between chronotype, social jetlag, sleep, obesity and blood pressure in healthy young adults. Chronobiol. Int. 2019, 36, 493–509. [Google Scholar] [CrossRef] [PubMed]
  17. Cespedes Feliciano, E.M.; Quante, M.; Rifas-Shiman, S.L.; Redline, S.; Oken, E.; Taveras, E.M. Objective Sleep Characteristics and Cardiometabolic Health in Young Adolescents. Pediatrics 2018, 142, e20174085. [Google Scholar] [CrossRef]
  18. Doyle, C.Y.; Ruiz, J.M.; Taylor, D.J.; Smyth, J.W.; Flores, M.; Dietch, J.R.; Ahn, C.; Allison, M.; Smith, T.W.; Uchino, B.N. Associations between objective sleep and ambulatory blood pressure in a community sample. Psychosom. Med. 2019, 81, 545–556. [Google Scholar] [CrossRef] [PubMed]
  19. Yang, Z.; Heizhati, M.; Wang, L.; Li, M.; Pan, F.; Wang, Z.; Abudureyimu, R.; Hong, J.; Yao, L.; Yang, W.; et al. Subjective Poor Sleep Quality is Associated with Higher Blood Pressure and Prevalent Hypertension in General Population Independent of Sleep Disordered Breathing. Nat. Sci. Sleep 2021, 13, 1759–1770. [Google Scholar] [CrossRef]
  20. Aggarwal, B.; Makarem, N.; Shah, R.; Emin, M.; Wei, Y.; St-Onge, M.P.; Jelic, S. Effects of Inadequate Sleep on Blood Pressure and Endothelial Inflammation in Women: Findings from the American Heart Association Go Red for Women Strategically Focused Research Network. J. Am. Heart Assoc. 2018, 7, e008590. [Google Scholar] [CrossRef]
  21. Lo, K.; Woo, B.; Wong, M.; Tam, W. Subjective sleep quality, blood pressure, and hypertension: A meta-analysis. J. Clin. Hypertens. 2018, 20, 592–605. [Google Scholar] [CrossRef]
  22. Yan, B.; Yang, J.; Zhao, B.; Fan, Y.; Wang, W.; Ma, X. Objective Sleep Efficiency Predicts Cardiovascular Disease in a Community Population: The Sleep Heart Health Study. J. Am. Heart Assoc. 2021, 10, e016201. [Google Scholar] [CrossRef] [PubMed]
  23. Hill, L.K.; Wu, J.Q.; Hinderliter, A.L.; Blumenthal, J.A.; Sherwood, A. Actigraphy-Derived Sleep Efficiency Is Associated with Endothelial Function in Men and Women with Untreated Hypertension. Am. J. Hypertens. 2021, 34, 207–211. [Google Scholar] [CrossRef]
  24. Massar, S.A.A.; Liu, J.C.J.; Mohammad, N.B.; Chee, M.W.L. Poor habitual sleep efficiency is associated with increased cardiovascular and cortisol stress reactivity in men. Psychoneuroendocrinology 2017, 81, 151–156. [Google Scholar] [CrossRef]
  25. Ross, A.J.; Yang, H.; Larson, R.A.; Carter, J.R. Sleep efficiency and nocturnal hemodynamic dipping in young, normotensive adults. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2014, 307, R888–R892. [Google Scholar] [CrossRef] [PubMed]
  26. Cintra, F.; Bittencourt, L.R.; Santos-Silva, R.; Andersen, M.; de Paola, A.; Poyares, D.; Tufik, S. The association between the Framingham risk score and sleep: A São Paulo epidemiological sleep study. Sleep Med. 2012, 13, 577–582. [Google Scholar] [CrossRef] [PubMed]
  27. Yan, B.; Zhao, B.; Fan, Y.; Yang, J.; Zhu, F.; Chen, Y.; Ma, X. The association between sleep efficiency and diabetes mellitus in community-dwelling individuals with or without sleep-disordered breathing. J. Diabetes 2020, 12, 215–223. [Google Scholar] [CrossRef] [PubMed]
  28. Zuurbier, L.A.; Luik, A.I.; Leening, M.J.; Hofman, A.; Freak-Poli, R.; Franco, O.H.; Stricker, B.H.; Tiemeier, H. Associations of heart failure with sleep quality: The Rotterdam study. J. Clin. Sleep Med. 2015, 11, 117–121. [Google Scholar] [CrossRef]
  29. Yu, J.M.; Tseng, I.J.; Yuan, R.Y.; Sheu, J.J.; Liu, H.C.; Hu, C.J. Low sleep efficiency in patients with cognitive impairment. Acta Neurol. Taiwan 2009, 18, 91–97. [Google Scholar]
  30. Horváth, A.; Montana, X.; Lanquart, J.P.; Hubain, P.; Szűcs, A.; Linkowski, P.; Loas, G. Effects of state and trait anxiety on sleep structure: A polysomnographic study in 1083 subjects. Psychiatry Res. 2016, 244, 279–283. [Google Scholar] [CrossRef]
  31. Papadimitriou, G.N.; Linkowski, P. Sleep disturbance in anxiety disorders. Int. Rev. Psychiatry 2005, 17, 229–236. [Google Scholar] [CrossRef]
  32. Farris, S.G.; Matsko, S.V.; Uebelacker, L.A.; Brown, R.A.; Price, L.H.; Abrantes, A.M. Anxiety sensitivity and daily cigarette smoking in relation to sleep disturbances in treatment-seeking smokers. Cogn. Behav. Ther. 2020, 49, 137–148. [Google Scholar] [CrossRef] [PubMed]
  33. Saletu-Zyhlarz, G.M.; Anderer, P.; Berger, P.; Gruber, G.; Oberndorfer, S.; Saletu, B. Nonorganic insomnia in panic Disorder: Comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolam. Hum. Psychopharmacol. 2000, 15, 241–254. [Google Scholar] [CrossRef] [PubMed]
  34. Uhde, T.W. Anxiety disorders. In Principles and Practice of Sleep Medicine; Kryger, M.H., Roth, T., Eds.; W. B. Saunders Company: Philadelphia, PA, USA, 2000; pp. 1123–1139. [Google Scholar]
  35. Alhalal, E.A.; Alhalal, I.A.; Alaida, A.M.; Alhweity, S.M.; Alshojaa, A.Y.; Alfaori, A.T. Effects of chronic pain on sleep quality and depression: A cross-sectional study. Saudi Med. J. 2021, 42, 315–323. [Google Scholar] [CrossRef] [PubMed]
  36. Abeler, K.; Friborg, O.; Engstrøm, M.; Sand, T.; Bergvik, S. Sleep Characteristics in Adults with and Without Chronic Musculoskeletal Pain: The Role of Mental Distress and Pain Catastrophizing. Clin. J. Pain 2020, 36, 707–715. [Google Scholar] [CrossRef] [PubMed]
  37. Keilani, M.; Crevenna, R.; Dorner, T.E. Sleep quality in subjects suffering from chronic pain. Wien. Klin. Wochenschr. 2018, 130, 31–36. [Google Scholar] [CrossRef] [PubMed]
  38. Nijs, J.; Mairesse, O.; Neu, D.; Leysen, L.; Danneels, L.; Cagnie, B.; Meeus, M.; Moens, M.; Ickmans, K.; Goubert, D. Sleep Disturbances in Chronic Pain: Neurobiology, Assessment, and Treatment in Physical Therapist Practice. Phys. Ther. 2018, 98, 325–335. [Google Scholar] [CrossRef]
  39. Gerhart, J.I.; Burns, J.W.; Post, K.M.; Smith, D.A.; Porter, L.S.; Burgess, H.J.; Schuster, E.; Buvanendran, A.; Fras, A.M.; Keefe, F.J. Relationships Between Sleep Quality and Pain-Related Factors for People with Chronic Low Back Pain: Tests of Reciprocal and Time of Day Effects. Ann. Behav. Med. 2017, 51, 365–375. [Google Scholar] [CrossRef]
  40. Simor, P.; Bódizs, R.; Horváth, K.; Ferri, R. Disturbed dreaming and the instability of sleep: Altered nonrapid eye movement sleep microstructure in individuals with frequent nightmares as revealed by the cyclic alternating pattern. Sleep 2013, 36, 413–419. [Google Scholar] [CrossRef]
  41. Fukui, S.; Ohama, E.; Hattori, S. Environmental factors related to sleep latency among inpatients in rehabilitation wards according to functional independence measure cognitive scores. Int. J. Nurs. Pract. 2022, 28, e12964. [Google Scholar] [CrossRef]
  42. Zandy, M.; Chang, V.; Rao, D.P.; Do, M.T. Tobacco smoke exposure and sleep: Estimating the association of urinary cotinine with sleep quality. Health Promot. Chronic Dis. Prev. Can. 2020, 40, 70–80. [Google Scholar] [CrossRef]
  43. Wang, L.; Heizhati, M.; Li, M.; Wang, Z.; Yang, Z.; Abudereyimu, R.; Yang, W.; Yao, L.; Li, N. Secondhand smoke is associated with poor sleep quality in self-reported never-smokers of Northwest China: A cross-sectional study. Sleep Breath. 2022, 26, 1417–1426. [Google Scholar] [CrossRef]
  44. Valentino, R.; D’Esposito, V.; Ariemma, F.; Cimmino, I.; Beguinot, F.; Formisano, P. Bisphenol A environmental exposure and the detrimental effects on human metabolic health: Is it necessary to revise the risk assessment in vulnerable population? J. Endocrinol. Invest. 2016, 39, 259–263. [Google Scholar] [CrossRef] [PubMed]
  45. Toyama, N.; Ekuni, D.; Taniguchi-Tabata, A.; Yoneda, T.; Kataoka, K.; Yokoi, A.; Uchida, Y.; Fukuhara, D.; Saho, H.; Monirul, I.M.; et al. Associations between sleep bruxism, sleep quality, and exposure to secondhand smoke in Japanese young adults: A cross-sectional study. Sleep Med. 2020, 68, 57–62. [Google Scholar] [CrossRef] [PubMed]
  46. Scheer, F.A.; Morris, C.J.; Garcia, J.I.; Smales, C.; Kelly, E.E.; Marks, J.; Malhotra, A.; Shea, S.A. Repeated melatonin supplementation improves sleep in hypertensive patients treated with beta-blockers: A randomized controlled trial. Sleep 2012, 35, 1395–1402. [Google Scholar] [CrossRef]
  47. Gubelmann, C.; Heinzer, R.; Haba-Rubio, J.; Vollenweider, P.; Marques-Vidal, P. Physical activity is associated with higher sleep efficiency in the general population: The colaus study. Sleep 2018, 41, zsy070. [Google Scholar] [CrossRef] [PubMed]
  48. Oudegeest-Sander, M.H.; Eijsvogels, T.H.; Verheggen, R.J.; Poelkens, F.; Hopman, M.T.; Jones, H.; Thijssen, D.H. Impact of physical fitness and daily energy expenditure on sleep efficiency in young and older humans. Gerontology 2013, 59, 8–16. [Google Scholar] [CrossRef] [PubMed]
  49. Glozier, N.; Martiniuk, A.; Patton, G.; Ivers, R.; Li, Q.; Hickie, I.; Senserrick, T.; Woodward, M.; Norton, R.; Stevenson, M. Short sleep duration in prevalent and persistent psychological distress in young adults: The DRIVE study. Sleep 2010, 33, 1139–1145. [Google Scholar] [CrossRef]
  50. Zhang, J.; He, M.; Wang, X.; Jiang, H.; Huang, J.; Liang, S. Association of sleep duration and risk of mental disorder: A systematic review and meta-analysis. Sleep Breath 2023, ahead of print. [CrossRef]
  51. Nagai, M.; Hoshide, S.; Kario, K. Sleep duration as a risk factor for cardiovascular disease—A review of the recent literature. Curr. Cardiol. Rev. 2010, 6, 54–61. [Google Scholar] [CrossRef]
  52. Lao, X.Q.; Liu, X.; Deng, H.B.; Chan, T.C.; Ho, K.F.; Wang, F.; Vermeulen, R.; Tam, T.; Wong, M.C.; Tse, L.A.; et al. Sleep quality, sleep duration, and the risk of coronary heart disease: A prospective cohort study with 60,586 adults. J. Clin. Sleep Med. 2018, 14, 109–117. [Google Scholar] [CrossRef]
  53. Chaudhry, B.A.; Brian, M.S.; Morrell, J.S. The Relationship between Sleep Duration and Metabolic Syndrome Severity Scores in Emerging Adults. Nutrients 2023, 15, 1046. [Google Scholar] [CrossRef]
  54. Van Cauter, E.; Spiegel, K.; Tasali, E.; Leproult, R. Metabolic consequences of sleep and sleep loss. Sleep Med. 2008, 9 (Suppl. S1), S23–S28. [Google Scholar] [CrossRef] [PubMed]
  55. Wang, C.; Colley, R.C.; Roberts, K.C.; Chaput, J.P.; Thompson, W. Sleep behaviours among Canadian adults: Findings from the 2020 Canadian Community Health Survey healthy living rapid response module. Health Rep. 2022, 33, 3–14. [Google Scholar] [CrossRef] [PubMed]
  56. Reed, D.L.; Sacco, W.P. Measuring sleep efficiency: What should the denominator be? J. Clin. Sleep Med. 2016, 12, 263–266. [Google Scholar] [CrossRef] [PubMed]
  57. Thomas, D.; Anderson, W.M. Multiple Sleep Latency Test (MSLT). In Encyclopedia of Sleep; Kushida, C.A., Ed.; Academic Press: Cambridge, MA, USA, 2013; pp. 96–99. [Google Scholar] [CrossRef]
  58. Zolovska, B.; Shatkin, J.P. Key Differences in Pediatric versus Adult Sleep. In Encyclopedia of Sleep; Kushida, C.A., Ed.; Academic Press: Cambridge, MA, USA, 2013; pp. 573–578. [Google Scholar] [CrossRef]
  59. Smith, M.T.; Haythornthwaite, J.A. How do sleep disturbance and chronic pain inter-relate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med. Rev. 2004, 8, 119–132. [Google Scholar] [CrossRef] [PubMed]
  60. Reading, C.L.; Wien, F. Health Inequalities and Social Determinants of Aboriginal Peoples’ Health; National Collaborating Centre for Aboriginal Health: Prince George, BC, Canada, 2009. [Google Scholar]
  61. The First Nations Information Governance Centre. First Nations Regional Health Survey (RHS) Phase 2 (2008/10): National Report on Adults, Youth and Children Living in First Nations Communities; The First Nations Information Governance Centre: Ottawa, ON, Canada, 2012. [Google Scholar]
  62. Gionet, L.; Roshanafshar, S. Health at a Glance: Select Health Indicators of First Nations People Living off Reserve, Metis and Inuit. In Health Research Working Paper Series; Statistics Canada Catalogue No. 82-624-X; Statistics Canada: Ottawa, ON, Canada, 2013; Available online: https://www150.statcan.gc.ca/n1/pub/82-624-x/2013001/article/11763-eng.pdf (accessed on 4 May 2023).
  63. Aili, K.; Åström-Paulsson, S.; Stoetzer, U.; Svartengren, M.; Hillert, L. Reliability of Actigraphy and Subjective Sleep Measurements in Adults: The Design of Sleep Assessments. J. Clin. Sleep Med. 2017, 13, 39–47. [Google Scholar] [CrossRef] [PubMed]
  64. Dosman, J.A.; Karunanayake, C.P.; Fenton, M.; Ramsden, V.R.; Seeseequasis, J.; Skomro, R.; Kirychuk, S.; Rennie, D.C.; McMullin, K.; Russell, B.P.; et al. Obesity, Sex, Snoring and Severity of OSA in a First Nation Community in Saskatchewan, Canada. Clocks Sleep 2022, 4, 100–113. [Google Scholar] [CrossRef]
  65. Dosman, J.A.; Karunanayake, C.P.; Fenton, M.; Ramsden, V.R.; Skomro, R.; Kirychuk, S.; Rennie, D.C.; Seeseequasis, J.; Bird, C.; McMullin, K.; et al. Prevalence of Insomnia in Two Saskatchewan First Nation Communities. Clocks Sleep 2021, 3, 98–114. [Google Scholar] [CrossRef]
  66. Karunanayake, C.P.; Fenton, M.; Skomro, R.; Ramsden, V.R.; Kirychuk, S.; Rennie, D.C.; Seeseequasis, J.; Bird, C.; McMullin, K.; Russell, B.P.; et al. Sleep Deprivation in two Saskatchewan First Nation Communities: A Public Health Consideration. Sleep Med. X 2021, 3, 100037. [Google Scholar] [CrossRef]
  67. Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Social Sciences and Humanities Research Council of Canada. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans—TCPS 2 (2018). December 2018. Available online: https://ethics.gc.ca/eng/documents/tcps2-2018-en-interactive-final.pdf (accessed on 31 August 2023).
  68. Tolonen, H.; Kuulasmaa, K.; Laatikainen, T.; Wolf, H. Recommendation for Indicators, International Collaboration, Protocol and Manual of Operations for Chronic Disease Risk Factor Surveys; for the European Health Risk Monitoring Project; Finnish National Public Health Institute: Helsinki, Finland, 2002; Available online: https://www.thl.fi/publications/ehrm/product2/product2.pdf (accessed on 25 October 2023).
  69. Buysse, D.J.; Reynolds III, C.F.; Monk, T.H.; Berman, S.R.; Kupfer, D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28, 193–213. [Google Scholar] [CrossRef]
  70. Eiman, M.N.; Pomeroy, J.M.L.; Weinstein, A.A. Relationship of actigraphy-assessed sleep efficiency and sleep duration to reactivity to stress. Sleep Sci. 2019, 12, 257–264. [Google Scholar] [CrossRef] [PubMed]
Table 1. Demographics of the study population.
Table 1. Demographics of the study population.
n (%)Mean AgeStandard Deviation of AgeMinimum AgeMaximum Age
All156 (100)37.814.91876
Male61 (39.1)35.014.61876
Females95 (60.9)39.614.91869
Table 2. Results from mean objective sleep measurements (actigraphy) and mean subjective measurements (using PSQI).
Table 2. Results from mean objective sleep measurements (actigraphy) and mean subjective measurements (using PSQI).
One-Night Actigraphy Data (n = 156)Self-Reported PSQI Scale Data (n = 153)
Mean ± SDMedian (Interquartile Range)Mean ± SDMedian (Interquartile Range)
Total time in bed, in hours6.91 ± 1.706.68 (2.49)8.39 ± 2.168.00 (3.00)
Total sleep time, in hours5.78 ± 1.565.78 (2.13)7.94 ± 2.197.92 (2.83)
Sleep onset latency, in minutes20. 74 ± 27.2514.00 (23.50)26.89 ± 26.8620.00 (20.00)
Sleep efficiency %83.38 ± 7.8483.92 (10.88)94.19 ± 6.1396.43 (5.12)
Wake time after sleep onset (WASO), in minutes38.06 ± 20.2335.25 (21.38)--
Number of awakes27.76 ± 12.4126.00 (15.00)--
Table 3. Univariable associations between factors and sleep efficiency (poor vs. good) (n = 156).
Table 3. Univariable associations between factors and sleep efficiency (poor vs. good) (n = 156).
VariablesTotal n (%)Sleep Efficiency n (%)p-Value OR (95% CI)p-Value
Good (>85%)Poor (≤85%)
Sex
Male61 (39.1)25 (35.7)36 (41.9)0.4341.30 (0.68, 2.48)0.434
Female95 (60.9)45 (64.3)50 (58.1) 1.00
Age groups
18–54 years127(81.4)55 (78.6)72 (83.7)0.4111.40 (0.62, 3.15)0.412
55 years and over29 (3.8)15 (21.4)14 (16.3) 1.00
Body Mass Index
Obese74 (47.4)33 (47.1)41 (47.7)0.6591.24 (0.58, 2.65)0.575
Overweight40 (25.6)16 (22.9)24 (27.9) 1.50 (0.62, 3.60)0.364
Neither overweight nor obese42 (26.9)21 (30.0)21 (24.4) 1.00
Education
High school not completed103 (66.5)50 (71.4)53 (62.4)0.2340.66 (0.34, 1.31)0.235
High school or above52 (33.5)20 (28.6)32 (37.6) 1.00
Money left over at the end of the month
Not enough money91 (59.5)39 (57.4)52 (61.2)0.6271.41 (0.65, 3.09)0.388
Just enough money27 (17.6)11 (16.2)16 (18.8) 1.54 (0.56, 4.25)0.404
Some money (ref)35 (22.9)18 (26.5)17 (20.0) 1.00
Drink caffeinated beverages within two hours of going to bed
Yes59 (38.6)23 (33.8)36 (42.4)0.2811.44 (0.74, 2.78)0.282
No94 (61.4)45 (66.2)49 (57.6) 1.00
Smoking status
Current smoker113 (72.4)48 (68.6)65 (75.6)0.3452.03 (0.77, 5.35)0.152
Ex-smoker23 (14.7)10 (14.3)13 (15.1) 1.95 (0.58, 6.58)0.282
Never smoker20 (12.8)12 (17.1)8 (9.3) 1.00
Physical activity at least 3 days per week
Yes76 (50.3)34 (50.7)42 (50.0)0.9270.97 (0.51, 1.85)0.927
No75 (49.7)33 (49.3)42 (50.0) 1.00
Taking any prescription medication on a regular basis
Yes70 (45.2)35 (50.0)35 (41.2)0.2720.70 (0.37, 1.32)0.273
No85 (54.8)35 (50.0)50 (58.8) 1.00
Sleep medication
Yes20 (13.0)8 (11.6)12 (14.1)0.6431.25 (0.48, 3.26)0.644
No134 (87.0)61 (88.4)73 (85.9) 1.00
Traditional medication used for sleep *
Yes4 (2.6)1 (1.4)3 (3.5)0.3862.52 (0.26, 24.82)0.427
No151 (97.4)69 (98.6)82 (96.5) 1.00
Ever had anxiety
Yes49 (35.0)22 (34.9)27 (35.1)0.9861.01 (0.50, 2.02)0.986
No91 (65.0)41 (65.1)50 (64.9) 1.00
Chronic pain
Yes44 (30.1)16 (23.5)28 (35.9)0.1041.82 (0.88, 3.76)0.106
No102 (69.9)52 (76.5)50 (64.1) 1.00
Ever had high blood pressure
Yes36 (27.1)11 (17.7)25 (35.2)0.0242.52 (1.12, 5.68)0.026
No97 (72.9)51 (82.3)46 (64.8) 1.00
Heart-related illness
Yes17 (10.9)9 (12.9)8 (9.3)0.4790.69 (0.25, 1.91)0.480
No139 (89.1)61 (87.1)78 (90.7) 1.00
Ever had a stroke *
Yes2 (1.3)1 (1.5)1 (1.2)0.7000.82 (0.05, 13.31)0.887
No149 (98.7)67 (98.5)82 (98.8) 1.00
Ever had high cholesterol
Yes18 (12.7)8 (11.9)10 (13.3)0.8031.13 (0.42, 3.07)0.803
No124 (87.3)59 (88.1)65 (86.7) 1.00
Ever had diabetes
Yes25 (17.5)10 (15.6)15 (19.0)0.5991.27 (0.53, 3.05)0.599
No118 (82.5)54 (84.4)64 (81.0) 1.00
Respiratory illness (COPD/EMP/Asthma/CB/PNEU)
Yes39 (25.0)14 (20.0)25 (29.1)0.1930.61 (0.29, 1.29)0.195
No117 (75.0)56 (80.0)61 (70.9) 1.00
Ever had reflux/heartburn
Yes54 (36.2)22 (32.8)32 (39.0)0.4341.31 (0.67, 2.57)0.435
No95 (63.8)45 (67.2)50 (61.0) 1.00
Depression
Yes45 (31.7)20 (32.3)25 (31.3)0.8980.95 (0.47, 1.95)0.898
No97 (68.3)42 (67.7)55 (68.8) 1.00
Ever sinus problems
Yes16 (10.8)6 (9.0)10 (12.3)0.5081.43 (0.49, 4.17)0.510
No132 (89.2)61 (91.0)71 (87.7) 1.00
Sleep Apnea *
Yes6 (4.5)1 (1.6)5 (6.9)0.1434.55 (0.52, 40.06)0.172
No128 (95.5)61 (98.4)67 (93.1) 1.00
Ever had post-traumatic stress disorder
Yes18 (12.6)7 (11.1)11 (13.8)0.4171.27 (0.46, 3.51)0.637
No125 (87.4)56 (88.9)69 (86.3) 1.00
Wake up during the night due to terrifying dreams or nightmares or flashbacks to a traumatic event
Yes71 (45.5)34 (48.6)37 (43.0)0.4890.80 (0.42, 1.51)0.489
No85 (54.5)36 (51.4)49 (57.0) 1.00
Wake up and get out of bed during the night
Never26 (16.8)12 (17.1)14 (16.5)0.4851.00
1–2 times91 (58.7)44 (62.9)47 (55.3) 0.92 (0.38, 2.19)0.843
3 or more times38 (24.5)14 (20.0)24 (28.2) 1.46 (0.53, 4.05)0.457
Housing Conditions
Crowding
≤2 people/bedroom114 (73.1)53 (75.7)61 (70.9)0.5031.00
>2 people/bedroom42 (26.9)17 (24.3)25 (29.1) 1.28 (0.62, 2.62)0.503
Damage caused by dampness
Yes85 (55.2)36 (52.9)49 (57.0)0.6171.18 (0.62, 2.23)0.617
No69 (44.8)32 (47.1)37 (43.0) 1.00
Moldy or musty smell
Yes82 (52.9)41 (59.4)41 (47.7)0.1450.62 (0.33, 1.18)0.146
No73 (47.1)28 (40.6)45 (52.3) 1.00
Signs of mold in any living areas in your house
Yes81 (52.9)32 (46.4)49 (58.3)0.1401.62 (0.85, 3.08)0.141
No72 (47.1)37 (53.6)35 (41.7) 1.00
Smoke inside home
Yes74 (48.4)26 (38.2)48 (56.5)0.0252.10 (1.09, 4.02)0.026
No79 (51.6)42 (61.8)37 (24.2) 1.00
* Variables with ≤5 cell sizes were not included in the logistic regression analysis.  p-values reported from the chi-squared test for measuring the association between outcome and independent factor.  p-values reported from the binary logistic regression analysis results. Heart-related illnesses were created by combining variables: ever having heart problems and ever having atrial fibrillation. Respiratory illnesses were created by combining variables: ever having COPD or emphysema, ever having asthma, ever having chronic bronchitis, and ever having pneumonia.
Table 4. Estimates of odds ratios (95% confidence intervals) and p-values based on multivariable logistic regression of the prevalence of poor sleep efficiency.
Table 4. Estimates of odds ratios (95% confidence intervals) and p-values based on multivariable logistic regression of the prevalence of poor sleep efficiency.
VariablesAdjusted Odds Ratio
(95% CI)
p-Value
Sex
Male0.90 (0.39, 2.10)0.811
Female1.00
Age groups
18–54 years4.82 (1.38, 16.84)0.014
55 years and over1.00
Taking any prescription medication on a regular basis
Yes0.54 (0.21, 1.37)0.537
No1.00
Chronic pain
Yes3.49 (1.28, 9.52)0.015
No1.00
Ever had high blood pressure
Yes4.32 (1.42, 13.20)0.010
No1.00
Smoke inside home
Yes2.92 (1.29, 6.58)0.010
No1.00
Table 5. Results of univariable and multivariable linear regression analyses of log-transformed sleep onset latency (N = 126).
Table 5. Results of univariable and multivariable linear regression analyses of log-transformed sleep onset latency (N = 126).
VariablesUnivariable RegressionMultivariable Regression
Unstandardized CoefficientsStd. Errorp-ValueUnstandardized Coefficients (Transformed Back to Original Scale)Std. Error (Transformed Back to Original Scale)p-Value
Sex
Male−0.0110.0760.882−0.095 (0.803)0.083 (1.210)0.259
Female (ref)
Age groups
18–54 years0.2060.1000.0410.255 (1.798)0.119 (1.315)0.034
55 years and over (ref)
Body Mass Index
Obese0.0420.0750.580
Overweight or neither overweight nor obese (ref)
Education
High school not completed0.1710.0770.028
High school or above (ref)
Money left over at the end of the month
Not enough money0.1290.0940.173
Just enough money0.0740.1210.545
Some money (ref)
Drink caffeinated beverages within two hours of going to bed
Yes−0.1200.0770.125
No (ref)
Smoking status
Current smoker0.1200.0840.153
Ex or never smoker (ref)
Never smoker
Physical activity at least 3 days per week
Yes0.0260.0770.741
No (ref)
Taking any prescription medication on a regular basis
Yes−0.1110.0750.141−0.075 (0.841)0.090 (1.230)0.405
No (ref)
Sleep medication
Yes0.1300.1140.255
No (ref)
Traditional medication used for sleep
Yes0.2620.2470.291
No (ref)
Ever had anxiety
Yes−0.1680.0840.050−0.188 (0.648)0.088 (1.225)0.034
No (ref)
Chronic pain
Yes0.0290.0880.7390.232 (1.706)0.099 (1.256)0.021
No (ref)
Ever had high blood pressure
Yes0.0610.0920.510
No (ref)
Heart-related illness
Yes−0.2830.1180.018−0.330 (0.468)0.132 (1.355)0.014
No (ref)
Ever had stroke
Yes0.0050.4320.991
No (ref)
Ever had high cholesterol
Yes0.0040.1190.974
No (ref)
Ever had diabetes
Yes−0.2060.1050.052
No (ref)
Respiratory illness (COPD/EMP/Asthma/CB/PNEU)
Yes−0.0350.0880.694
No (ref)
Ever had reflux/heartburn
Yes−0.0290.0820.726
No (ref)
Depression
Yes−0.1040.0830.214
No (ref)
Ever sinus problems
Yes−0.1080.1310.412
No (ref)
Sleep Apnea
Yes−0.2590.1920.180
No (ref)
Ever had post-traumatic stress disorder
Yes−0.2760.1210.024
No (ref)
Wake up during the night due to terrifying dreams or nightmares or flashbacks to a traumatic event
Yes−0.0320.0750.674
No (ref)
Wake up and get out of bed during the night
Never (ref)ref
1–2 times−0.0570.1110.611
3 or more times−0.1380.1240.269
Housing Conditions
Crowding
≤2 people/bedroom (ref)
>2 people/bedroom0.1240.0850.146
Damage caused by dampness
Yes−0.1250.0750.096
No (ref)
Moldy or musty smell
Yes−0.1130.0740.133
No (ref)
Signs of mold in any living areas in your house
Yes0.0510.0760.507
No (ref)
Smoke inside home
Yes0.1360.0740.0670.247 (1.766)0.083 (1.210)0.003
No (ref)
Heart-related illnesses were created by combining variables: ever having heart problems and ever having atrial fibrillation. Respiratory illnesses were created by combining variables: ever having COPD or emphysema, ever having asthma, ever having chronic bronchitis, and ever having pneumonia. Note: ‘ref’ refers to the reference category of the categorical variable.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Karunanayake, C.P.; Pahwa, P.; Kirychuk, S.; Fenton, M.; Ramsden, V.R.; Seeseequasis, J.; Seesequasis, W.; Skomro, R.; Rennie, D.C.; McMullin, K.; et al. Sleep Efficiency and Sleep Onset Latency in One Saskatchewan First Nation. Clocks & Sleep 2024, 6, 40-55. https://doi.org/10.3390/clockssleep6010004

AMA Style

Karunanayake CP, Pahwa P, Kirychuk S, Fenton M, Ramsden VR, Seeseequasis J, Seesequasis W, Skomro R, Rennie DC, McMullin K, et al. Sleep Efficiency and Sleep Onset Latency in One Saskatchewan First Nation. Clocks & Sleep. 2024; 6(1):40-55. https://doi.org/10.3390/clockssleep6010004

Chicago/Turabian Style

Karunanayake, Chandima P., Punam Pahwa, Shelley Kirychuk, Mark Fenton, Vivian R. Ramsden, Jeremy Seeseequasis, Warren Seesequasis, Robert Skomro, Donna C. Rennie, Kathleen McMullin, and et al. 2024. "Sleep Efficiency and Sleep Onset Latency in One Saskatchewan First Nation" Clocks & Sleep 6, no. 1: 40-55. https://doi.org/10.3390/clockssleep6010004

APA Style

Karunanayake, C. P., Pahwa, P., Kirychuk, S., Fenton, M., Ramsden, V. R., Seeseequasis, J., Seesequasis, W., Skomro, R., Rennie, D. C., McMullin, K., Russell, B. P., Koehncke, N., Abonyi, S., King, M., & Dosman, J. A. (2024). Sleep Efficiency and Sleep Onset Latency in One Saskatchewan First Nation. Clocks & Sleep, 6(1), 40-55. https://doi.org/10.3390/clockssleep6010004

Article Metrics

Back to TopTop